GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » LT-Debt-to-Total-Asset

Biomics Biopharma (ASX:BBM) LT-Debt-to-Total-Asset : 0.00 (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Biomics Biopharma's long-term debt to total assests ratio for the quarter that ended in . 20 was 0.00.

Biomics Biopharma's long-term debt to total assets ratio stayed the same from . 20 (0.00) to . 20 (0.00).

Biomics Biopharma LT-Debt-to-Total-Asset Historical Data

The historical data trend for Biomics Biopharma's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma LT-Debt-to-Total-Asset Chart

Biomics Biopharma Annual Data
Trend
LT-Debt-to-Total-Asset

Biomics Biopharma Semi-Annual Data
LT-Debt-to-Total-Asset

Biomics Biopharma LT-Debt-to-Total-Asset Calculation

Biomics Biopharma's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in . 20 is calculated as

LT Debt to Total Assets (A: . 20 )=Long-Term Debt & Capital Lease Obligation (A: . 20 )/Total Assets (A: . 20 )
=/
=

Biomics Biopharma's Long-Term Debt to Total Asset Ratio for the quarter that ended in . 20 is calculated as

LT Debt to Total Assets (Q: . 20 )=Long-Term Debt & Capital Lease Obligation (Q: . 20 )/Total Assets (Q: . 20 )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomics Biopharma  (ASX:BBM) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Biomics Biopharma LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomics Biopharma (ASX:BBM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » LT-Debt-to-Total-Asset
Comparable Companies
ASX:G88 ASX:ELS ASX:BHD ASX:IBX ASX:ZEN ASX:OLI ASX:KPG ASX:CAN ASX:MPW ASX:CQG ASX:OCA
Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Website
http://www.biomics.com
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines